lung fibrosis scarring of the long
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -IPF patients -Diagnosis of IPF, including probable and possible diagnosis according to ATS/ERS criteria -Written informed consent -TLCOc >= 25% (pred) and FVC >= 50% (pred) -6MWD >= 150 m -Being clinically stable -Absolute decline in TLCOc and FVC should be less than 10% in the past 6 months.
Exclusion criteria
Exclusion criteria: -Participation in a formal rehabilitation program within 4 months of start of study -Musculoskeletal disorders -Severe cardiac diseases (ejection fraction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in total score in health-related quality of life questionnaire SGRQ , measured at week 9 and week 18 compared to baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in exercise capacity measures at week 9 and week 18 compared to baseline (distance (m) during 6-minute-walk-test and average steps per day) Change in score in health related quality of life questionnaires K-BILD abd GAD-7 , measured at 9 and 18 weeks compared with baseline. This questionnaire is self-administered. Change in component scores (symptoms, activity and impact) in health-related quality of life measured with SGRQ at week 9 and 18 compared to baseline. | — |
Countries
Netherlands